glp 1 from china approves first home-grown GLP-1 weight loss drug, rivaling Ozempic | Yanzhong Huang posted on the topic Updated] GLP-1-RAs Swoop to Chinese

Exenatide extended-release (Bydureon/BCise) carries a boxed warning regarding thyroid C-cell tumors based on rodent studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

Heres how the authors explained this this: in the early stages of the disease, the gut makes a lot of GLP-1 to manage blood sugar

Saxenda vs Ozempic: For Weight Loss

A few other states are planning or considering obesity drug restrictions in state fiscal year 2026 or 2027, and state interest in expanding coverage of obesity drugs is also waning according to this years survey, with states continuing to report cost as the key factor contributing to obesity drug coverage decisions

Analysts have projected that the drug could fetch $26 billion in annual sales by 2030, with roughly two-thirds of that sum related to obesity treatment

Now I track my water intake religiously when Im sick. Robert G